|Application ||WB, IHC-P, E|
|Dilution||ELISA (1 µg/ml), IHC-P (10 µg/ml), WB (1 µg/ml)|
|Other Names||Protein NOV homolog, NovH, CCN family member 3, Insulin-like growth factor-binding protein 9, IBP-9, IGF-binding protein 9, IGFBP-9, Nephroblastoma-overexpressed gene protein homolog, NOV, CCN3, IGFBP9, NOVH|
|Target/Specificity||synthetic peptide corresponding to C-terminal residues of human NOV protein homolog precursor (NovH) (Nephroblastoma overexpressed gene protein homolog)|
|Reconstitution & Storage||+4°C or -20°C, Avoid repeated freezing and thawing.|
|Precautions||CCN3 / NOV Antibody (C-Terminus) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Synonyms||CCN3, IGFBP9, NOVH|
|Function||Immediate-early protein likely to play a role in cell growth regulation.|
|Tissue Location||Expressed in bone marrow, thymic cells and nephroblastoma. Increased expression in Wilms tumor of the stromal type.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Immediate-early protein likely to play a role in cell growth regulation.
Martinerie C.,et al.Oncogene 9:2729-2732(1994).
Martinerie C.,et al.Oncogene 12:1479-1492(1996).
Jiang D.,et al.Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Ebert L.,et al.Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.